• Multiple major banks raised price targets on dozens of stocks, signaling broad optimism about earnings resilience.
  • Notable double-digit percentage increases for Adaptive Biotechnologies, Fortinet, and Extra Space Storage.
  • Upgrades span sectors from biotech to defense and real estate, reflecting confidence in sector rotations.

Wave of Target Hikes

A flurry of analyst price-target increases swept across the market this week, with JP Morgan, RBC, Jefferies, Piper Sandler, and KBW among the banks lifting their outlooks on a wide range of names. The moves, concentrated in technology, healthcare, and industrials, suggest a growing conviction that companies can navigate a murky macroeconomic backdrop.

Biogen (BIIB) saw its target raised to $210 from $185 at JP Morgan, while TD Cowen set a new target of $225, up from $215. Fortinet (FTNT) was a standout, with multiple upgrades: BTIG raised its target to $203 from $186, Jefferies to $190 from $165, and RBC to $185 from $160. “The cybersecurity demand environment remains favorable,” one analyst noted, speaking on condition of anonymity.

Healthcare and Biotech Lead

Adaptive Biotechnologies (ADPT) received a boost from JP Morgan, which upped its price target to $27 from $25, while TD Cowen lifted its target to $28. The company, focused on immune sequencing, has been expanding its clinical pipeline. Meanwhile, GE HealthCare (GEHC) saw Jefferies raise its target to $92 from $90, reflecting steady demand for diagnostic imaging equipment.

In the biotech space, CSL’s target was lifted to $450 from $420 by JP Morgan, and CORT received a massive hike from Piper Sandler to $165 from $88. The breadth of upgrades indicates a sector-wide reassessment of growth prospects.

Real Estate and Services

Extra Space Storage (EXR) saw its target rise to $157 from $153 at RBC, while CBRE Group (CBRE) got a lift to $174 from $158 from KBW. “Self-storage fundamentals remain solid, with occupancy holding up well,” a real estate analyst said. Logistics firm CH Robinson (CHRW) also benefited, with JP Morgan raising its target to $225 from $198.

Defense and Industrial

General Dynamics (GD) received upgrades from multiple firms: JP Morgan raised its target to $435 from $400, Morgan Stanley to $465 from $435, and RBC to $410 from $385. The defense contractor’s backlog and government demand appear to underpin analyst confidence.

Broader Context

The wave of target increases comes amid a market that has been cautiously optimistic, with investors balancing rate uncertainty against resilient corporate earnings. Analysts appear to be betting that companies can sustain margins and growth even if the economy slows. “These upgrades reflect a belief that the earnings cycle still has legs,” said one strategist.

Correction: An earlier version of this article misstated the ticker for Avnet as AVTR; AVTR refers to Avantor. The error has been corrected.